Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 5.74 Delayed Data As of 12:48pm ET |  +0.14 / +2.50%Today’s Change | 1.45 Today|||52-Week Range 9.40 | +8.92% Year-to-Date |
| Conatus (CNAT) Up 7% Since Earnings Report: Can It Continue? Sep 08 / Zacks.com - Paid Partner Content |
| Previous close | 5.60 |
| Today’s open | 5.59 |
| Day’s range | 5.56 - 5.74 |
| Volume | 87,324 |
| Average volume (3 months) | 592,870 |
| Market cap | $168.0M |
| Dividend yield | -- |
| Earnings growth (last year) | -0.77% |
| Earnings growth (this year) | +66.03% |
| Earnings growth (next 5 years) | +74.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 149.38 |
| Price/Book | 6.71 |
| Today’s change | Today’s % change | |
|---|---|---|
| BDSIBioDelivery Sciences... | +0.02 | +0.92% |
| ALRNAileron Therapeutics... | +0.20 | +1.70% |
| ADMPAdamis Pharmaceutica... | +0.10 | +1.96% |
| OCXOncoCyte Corp | +0.05 | +0.77% |
| Next reporting date | November 8, 2017 |
| EPS forecast (this quarter) | $0.02 |
| Annual revenue (last year) | $799.0K |
| Annual profit (last year) | -$29.7M |
| Net profit margin | -3,721.12% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Steven J. Mento |
Executive VP, Chief Operating & Financial Officer Keith W. Marshall |
Corporate headquarters San Diego, California |
